A phase II study of vinorelbine and estramustine in patients with hormone-resistant prostate cancer.

Introduction: This phase II study was designed to evaluate the efficacy of vinorelbine in combination with estramustine in patients with chemotherapy-naïve hormone-refractory prostate cancer.

Material And Methods: Patients received vinorelbine (i.v.